Tuttle Capital Management, LLC Eli Lilly & CO Transaction History

Tuttle Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 20, 2021	SELL	$130.46 - $172.63 $635,340 - $840,708	-4,870 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $712,091 - $823,663	4,870 New	4,870 $721,000
Q2 2019 Jul 29, 2019	SELL	$110.79 - $129.32 $4.88 Million - $5.7 Million	-44,079 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $3.56 Million - $4.19 Million	31,983 Added 264.41%	44,079 $5.72 Million
Q4 2018 Jan 31, 2019	SELL	$105.9 - $118.64 $212,223 - $237,754	-2,004 Reduced 14.21%	12,096 $2.23 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $1.21 Million - $1.51 Million	14,100 New	14,100 $1.51 Million

4,010

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Tuttle Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tuttle Capital Management, LLC with notifications on news.